Deferasirox prevents progression of non-alcoholic steatohepatitis in a mouse model with inhibition of heaptic fibrosis and hepatocellular ballooning

被引：0
|
作者：
Korenaga, Masaaki [1 ]
Korenaga, Keiko [1 ]
Mizokami, Masashi [1 ]
Kanto, Tatsuya [1 ]
机构：
[1] Natl Ctr Global Hlth & Med NCGM Kohnodai, Res Ctr Hepstitis & Immunol, Ichikawa, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1583
引用
收藏
页码：785A / 786A
页数：2
相关论文
共 50 条
  • [41] Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
    Rios, Rafael S.
    Zheng, Kenneth, I
    Zheng, Ming-Hua
    CHINESE MEDICAL JOURNAL, 2021, 134 (24) : 2911 - 2921
  • [42] Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
    Cuadrado, A
    Orive, A
    García-Suárez, C
    Domínguez, A
    Fernández-Escalante, JC
    Crespo, J
    Pons-Romero, F
    OBESITY SURGERY, 2005, 15 (03) : 442 - 446
  • [43] Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
    Rafael S. Rios
    Kenneth I. Zheng
    Ming-Hua Zheng
    中华医学杂志英文版, 2021, 134 (24) : 2911 - 2921
  • [44] Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
    Shimada, M
    Hashimoto, E
    Taniai, M
    Hasegawa, K
    Okuda, H
    Hayashi, N
    Takasaki, K
    Ludwig, J
    JOURNAL OF HEPATOLOGY, 2002, 37 (01) : 154 - 160
  • [45] MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
    Sakamoto, Hiroki
    Miyanishi, Koji
    Tanaka, Shingo
    Ito, Ryo
    Hamaguchi, Kota
    Sakurada, Akira
    Sato, Masanori
    Kubo, Tomohiro
    Osuga, Takahiro
    Murase, Kazuyuki
    Takada, Kohichi
    Nakabeppu, Yusaku
    Kobune, Masayoshi
    Kato, Junji
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
    Hiroki Sakamoto
    Koji Miyanishi
    Shingo Tanaka
    Ryo Ito
    Kota Hamaguchi
    Akira Sakurada
    Masanori Sato
    Tomohiro Kubo
    Takahiro Osuga
    Kazuyuki Murase
    Kohichi Takada
    Yusaku Nakabeppu
    Masayoshi Kobune
    Junji Kato
    Scientific Reports, 11
  • [47] Hepatocellular carcinoma arising in non-alcoholic steatohepatitis
    Zen, Y
    Katayanagi, K
    Tsuneyama, K
    Harada, K
    Araki, I
    Nakanuma, Y
    PATHOLOGY INTERNATIONAL, 2001, 51 (02) : 127 - 131
  • [48] SILYMARIN IMPROVES FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS
    Chan, W. K.
    Mustapha, N. R. N.
    Mahadeva, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S225 - S226
  • [49] Predictive factors for fibrosis in non-alcoholic steatohepatitis
    Sarioglu, M
    Uzunalimogiu, O
    Erden, E
    Cicek, B
    Cetinkaya, H
    Cinar, K
    Mas, R
    Ozenirler, S
    Bozdayi, M
    Bozkaya, H
    JOURNAL OF HEPATOLOGY, 2003, 38 : 200 - 200
  • [50] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
12345